The tariff classification of Potassium Chloride Extended-Release Capsules, Famotidine Tablets, Fluoxetine Capsules, and Levetiracetam Tablets in dosage form, from India
Reasoning
The tariff classification of Potassium Chloride Extended-Release Capsules, Famotidine Tablets, Fluoxetine Capsules, and Levetiracetam Tablets in dosage form, from India
Cite this ruling
CBP Ruling N304542 (3004909235): The tariff classification of Potassium Chloride Extended-Release Capsules, Famotidine Tablets, Fluoxetine Capsules, and Levetiracetam Tablets in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of acetaminophen tablets and caplets from China
The tariff classification of children’s aspirin tablets, enteric-coated aspirin tablets, and calcium carbonate antacid tablets from China
The tariff classification of children’s aspirin tablets, enteric-coated aspirin tablets, and calcium carbonate antacid tablets from China
The tariff classification of ANTEGREN® (natalizumab) mixed with excipients and imported in bulk form, and ANTEGREN® (natalizumab) mixed with excipients and imported put up in single-dose vials, from Germany and other countries
Modification of New York Ruling Letter (NYRL) K84840, dated April 20, 2004, concerning cherry flavored cough suppressant lozenge